Metronidazol Viaflo Baxter (Metronidazole)

Metronidazole is taken up by anaerobic bacteria and protozoa and reduced to a nitro radical anion. This reactive form binds to DNA, causing strand breakage and blocking nucleic acid synthesis, which leads to cell death of the targeted microorganisms.

The specific dose and duration are determined by the prescribing clinician based on the infection type, severity, patient weight, renal function and other clinical factors. No standard dosing regimen is provided here.

Metronidazole is classified as Pregnancy Category B, indicating that animal studies have not shown risk but there are limited human data. It is excreted in breast milk, so clinicians weigh the benefits against potential risks before prescribing to pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Metronidazole is a nitroimidazole that offers broad activity against anaerobic bacteria and protozoa, often preferred for its oral and IV formulations. Alternatives such as tinidazole or ornidazole have similar mechanisms but may differ in dosing frequency, half‑life and side‑effect profiles.

Metronidazol Viaflo Baxter should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Maintaining the cold chain preserves the stability and sterility of the injectable solution.

The product is supplied as a sterile injection solution for intravenous infusion. Administration is performed by qualified healthcare professionals under aseptic conditions, following the prescribed infusion rate and monitoring for any adverse reactions.

Serious risks include peripheral neuropathy, severe allergic reactions such as anaphylaxis, and liver toxicity. Patients should be monitored for neurological symptoms, skin rash, or signs of hepatic dysfunction, and therapy should be discontinued if these occur.

Metronidazol Viaflo Baxter is contraindicated in patients with a known hypersensitivity to metronidazole or other nitroimidazole derivatives. Caution is also advised for individuals with severe hepatic impairment, and it should be avoided in patients who have consumed alcohol within 24 hours of dosing.